SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-012005
Filing Date
2023-04-12
Accepted
2023-04-12 16:54:07
Documents
96
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2360113
2 ex4-12.htm EX-4.12 16814
3 ex21.htm EX-21 5335
4 ex23-1.htm EX-23.1 3948
5 ex31-1.htm EX-31.1 19355
6 ex31-2.htm EX-31.2 19331
7 ex32-1.htm EX-32.1 8787
  Complete submission text file 0001493152-23-012005.txt   11554544

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ocx-20221231.xsd EX-101.SCH 95156
9 XBRL CALCULATION FILE ocx-20221231_cal.xml EX-101.CAL 97680
10 XBRL DEFINITION FILE ocx-20221231_def.xml EX-101.DEF 467499
11 XBRL LABEL FILE ocx-20221231_lab.xml EX-101.LAB 736815
12 XBRL PRESENTATION FILE ocx-20221231_pre.xml EX-101.PRE 605114
90 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1770354
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37648 | Film No.: 23816233
SIC: 2835 In Vitro & In Vivo Diagnostic Substances